Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-24 @ 11:55 PM
NCT ID:
NCT05195151
Eligibility Criteria:
Inclusion Criteria:
* Men and women
* aged 65-89 years
* who have received 3 doses of a mRNA vaccine (Pfizer-BioNTech or Moderna) for more than 6 months;
* volunteered for a booster dose
* had telephone or internet access
* were able to provide informed consent
* lived \<75 km from the CRC (subgroup of 100 participants only)
Exclusion Criteria:
* Patients with COVID-19 disease (clinical and serological data at post);
* with possibly affected cognitive functions (score \< 12 on the Functional Activities Questionnaire (FAQ))
* with allergies (soy, lactose, yeast, maltodextrin)
* with a chronically weakened immune system (AIDS...)
* undergoing anti-cancer treatment (chemotherapy or radiotherapy)
* who do not speak French or English.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
89 Years
Study:
NCT05195151
Study Brief:
Protocol Section:
NCT05195151